Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

Title
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Authors
Keywords
Cerebrospinal fluid, Biomarkers, Alzheimer's disease, β-Amyloid, Tau protein, Mild cognitive impairment
Journal
Alzheimers & Dementia
Volume 11, Issue 1, Pages 58-69
Publisher
Elsevier BV
Online
2014-05-03
DOI
10.1016/j.jalz.2014.02.004

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started